AI assistant
Khiron Life Sciences Corp. — Board/Management Information 2020
Jun 15, 2020
47040_rns_2020-06-15_e3bb77b4-4c52-4542-8124-0cd0cba822ce.pdf
Board/Management Information
Open in viewerOpens in your device viewer
FORM 51-102F3
MATERIAL CHANGE REPORT
Item 1. Name and Address of Company Khiron Life Sciences Corp. (the “ Company ”) 2300 – 500 Burrard Street Vancouver, BC V6C 2B5
-
Item 2. Date of Material Change June 12, 2020
-
Item 3. News Release A press release was issued through CNW on June 12, 2020, and subsequently filed on SEDAR.
-
Item 4. Summary of Material Change
The Company announced changes to its board of directors.
Item 5. Full Description of Material Change 5.1 Full Description of Material Change
-
On June 12, 2020, the Company announced the resignation of Michael Beck Monaghan from its board of directors and the concurrent appointment of Chris Naprawa as a director and Chair of the Board of Directors of the Company.
-
5.2 Disclosure for Restructuring Transactions
Not Applicable.
Item 6. Reliance on Subsection 7.1(2) or (3) of National Instrument 51-102 – Continuous Disclosure Obligations
Not Applicable.
-
Item 7. Omitted Information None.
-
Item 8. Executive Officer Knowledgeable of Material Change
Wendy Kauffman Chief Financial Officer (647) 556-5750
- Item 9. Date of Report June 15, 2020